Evomela
(eh-voh-MEH-lah)
A drug that contains the active ingredient melphalan hydrochloride and is given as an infusion to prepare patients with multiple myeloma for a stem cell transplant. It is also being studied in the treatment of other types of cancer. Evomela may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent.